The association between social support and chemotherapy-related toxicity in older patients with cancer. Academic Article uri icon

Overview

abstract

  • OBJECTIVES: The goal of this study was to evaluate the relationship between social support (SS) and grade 3-5 chemotherapy-related toxicities among older adults with cancer. METHODS: This is a secondary analysis of a prospective longitudinal study of patients aged 65+ with solid cancer which led to the development of a predictive model for grade 3-5 chemotherapy-related toxicity (the Cancer and Aging Research Group [CARG] Chemotherapy Toxicity Risk Score). SS was measured by a modified version of Medical-Outcome Study-Social Support Survey and grade 3-5 hematological and non-hematological toxicities were captured and graded using CTCAE version 3.0. Patients were categorized into those with poor (SS score ≤ 75) and good SS (score of 76-100). Multivariate polychotomous logistic regression was used to examine the associations between SS and chemotherapy-related toxicity with adjustment for the CARG Toxicity Risk Score. RESULTS: Compared to patients with good SS, those with poor SS were less likely to have grade 3-5 toxicity, especially for non-hematological toxicity (adjusted OR = 0.52, p = .02). Patients who did not have someone to take them to the doctor "most" or "all of the time" were less likely to have grade 3-5 non-hematological toxicity compared to patients who had someone to take them to the doctor most or all of the time (adjusted OR = 0.32, p = .02). CONCLUSION: Our study showed that patients with poor SS, especially those with less availability of someone to take them to doctors were less likely to have a documented grade 3-5 non-hematological toxicity.

authors

  • Shahrokni, Armin
  • Sun, Can-Lan
  • Tew, William P
  • Mohile, Supriya Gupta
  • Ma, Huiyan
  • Owusu, Cynthia
  • Klepin, Heidi D
  • Gross, Cary Philip
  • Lichtman, Stuart M
  • Gajra, Ajeet
  • Katheria, Vani
  • Cohen, Harvey Jay
  • Hurria, Arti

publication date

  • September 26, 2019

Research

keywords

  • Antineoplastic Agents
  • Neoplasms

Identity

PubMed Central ID

  • PMC7054161

Scopus Document Identifier

  • 85071863845

Digital Object Identifier (DOI)

  • 10.1016/j.jgo.2019.08.015

PubMed ID

  • 31501014

Additional Document Info

volume

  • 11

issue

  • 2